Article History
Received: 13 December 2024
Revised: 4 March 2025
Accepted: 20 March 2025
First Online: 15 April 2025
Competing interests
: PL has filled patents on the use of therapeutics targeting CD95/CD95L (WO2014118317; WO2015189236; WO2015158810; WO2015104284; WO2017149012; WO2018130679; WO2023161412; WO2023099578). The rest of the authors has no conflicts of interest to declare regarding this manuscript.